_id
690f3853ccc777a4e85d1854
Ticker
BRKR
Name
Bruker Corporation
Exchange
NASDAQ
Address
40 Manning Road, Billerica, MA, United States, 01821
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.bruker.com
Description
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.
Last Close
46.37
Volume
2520355
Current Price
45.13
Change
-2.674142764718557
Last Updated
2025-11-28T13:08:00.356Z
Image
data:image/webp;base64,UklGRqAIAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSOEEAAABoIVt+/lGer7v92ume41trW3btm3btr3bpm7Trm0bY9sza9uo8h7kn+x/rz3ck4iYAP6nGvw/4jGAheiYpWEhFoZ/wSma2WZ5/B9YiEZR97Sc0Xe88vKLzzx44dP6aT0yXoJHA/psftiF11577sZmlk5gnz8f2HHU0FV2vL6jVY9HLHqCByjb+u6FeemXDxZ/qWmjsDSMrp8dhlP4rn55dU7VaCwYFowhV36u/Izrdx4SMRv2+MJyLIXATrMIwcwi/U/flpXqFjeOwKMzvKZVi88dipHovH4yIZVdZ5JsBm70ufWDO3rT+7Y2Pb99AIvBzcwynFZNTMEZ+d1KeAEWAx6N4fVjLluql9bALDpFA2felQqw8EpiQrJ3oftk6Sw8BKPEQNORhDQil33fHSvBAwf81n72wXMvxAIlGr3eH4ilYfT/405isUCmRjPXhOFvvN6fWELkwmoCqQau0sZ4kjN6mu6JxGCcv2R7giUZA2atiJfkMTkY3T/9sLuVxWhEDvyj9XDKygiZDBstvhzHY4wxw1O3kYnJVlCqs9XnpxDAnB0WLN0cJzGy3APnYgDOpk8ZxQ2cI1uyVdlstulEetxTWXdfNlt3UQ8ufTq3PJvncrtwUkvV8HDpna/cwBEt2apsRS63Pxc2ZbPZytpbRmORh9QuKa+O5Xv/obykDlUwW/lNOUG6gqfVsUGt9PkmPKJ2Se3KMUUdkjo12YjkpIpN9v1C3w/p/bO+PWjrSmkMU9S2McdJl/CkfhyT18ShkJMqdjlw//3XYIzaL9zy7Nb8zwOJtCj/2dS5bXqQIb+pdc6YD6R7manOTTlBupRn1K5WvUA5Ler86bNPfz8Axqlz2bhZnZpEgha88tICafuuf6rt8468arowQ/lNOF66jGeU/+3nvM6EFmnp+2Pn7Jzw5W/SxKFYJCc1H3jgU9LJ5b/qS+6SWuA96f493pFO4klpr6PV8eNqBU1HnHLi2VsxVlp7d2lO14KH1C4pL23Q4w99W973C+lYDmlTXp2a1o8n1bEBr0vTeFDtktqVY7K0Na9KDbhzVHNlZUVFRd2B9Ly7+qa+7NPUcAFsdGVjc9PR3YzjmytHs8JdDzy00sH3ZbOVFY11+3NRU82KrNVQc3dXSjZn4w8uJgDOHrPfXRUzAwjE+gswAGeLh0g2kj0mB6Prki/7EGN0jOPa/tif4HimC6vPuZVgHmOMGV68li4xGh5jKCgxcKG2xkkMrD5H1xshOCd+sDeBZGPItBEYaRo9f6oiUDTQtUXjV4YBL4wZTrQiRK6+m5BK4IJfemPFcOfYv/4+ea/515sFSjT6vd8PS8OYdwORUj1D3+nS2XgsiUDzYYQUjOHfr4InWAxYdAbcPenmT/TYCphFK+Xs24kpBHaebVgSuNHj8g/qBzGgNt/50MYGHoMZWBmn1Ke003RCMLNAzyM2Ydgt8x9eBY/Gig90aOaJ/THAHOe50wkpGD2+2IdA4cv68en5962GBcODMfr279T+/oVb9DGMPvXLumEpEDj0r6qNB/QdsdllHX/rha5YcAo9QPmuDZ9J+a/mzvhAi1fGSdVZve6NN196/omrX9Vfm5BxinsEbNgOp1xzb9WV20eMlB3IlBuU774mTukWIsXNSd2jASEaGP/cPMTCYPyrZoAF53+zAFZQOCCYAwAA8BEAnQEqQABAAD61SJ1LpyOioawarADgFolsAMqr3z7ftPmqV1uCBm6/H6Qe4D8iegB0gPMB+y3rPehj0AP6f1AHPzexT+7nppZoB/JX5EsCDWZIvKZ2iPWfQdbVATu1UcraREY+OxJEnoMg8awZjXPcUWhZ51tg3t+jsyIOlo1OApiSId6JnHJTuhwsZ/W5Omac9ohFsgAA/vshf/7rD/9p3//3K54A9x39DWid4YLJD87T5tanHzEuULDIfR+/4TqTjwUCPERM9jrNW/ZjjkPKEGLmXky9Gu2Z2L2Rh/vsIwZNP78f/Xo9+eLk7rjiJWQ639Cd5fy5xJYwkCFRbhrRV50n7h/gsw97C8v7Ba/8jnZsQPeNYla/B02nTRoLyUdNog/LMcDsPu/YkPQR1VRW5LRe1D0fcxKjLdDpHCpZD3RHAazJ35IhIRHjYVcWVK5CQRN3/X57SKWBKV1phncJBVgliUN3gKqTgVgfjo6+ZJ0pAR8TFuXRHrB51X5juMgfYvts97vdOIS+strdENmBqt1/1vUpbPKNaBkCEXxGYhZ6oiX3xU+OTe2V5Df8GoAoGXwzgbr0BCg4vlcg5Xv98F+dB7C7jwXcRhrGbAT3nZZzvWMlbrvBM8VHdsaEwNPw44ipX/DYwDo4nQezouGwEQ6MNGFdP4DgqAVt3dv8XRuH2i9aKeAO+VNHmaJ5/XQn40wFXd+iNIaoaRt9gbQSTfZ445P4pt4BXst0lMzo9OZZoah7uOAefcssSBhQ12vmR/E2SP0eW0uHjhd3tKCwoLoZL+FBHIkpdUZrOzcgrtKU4YjyyOKzpPHOsyArOMgX+xh45/n9RS0HndX3M9cWLbxQVcwz8BW1ahDGnBL3bYI4TT2mmoGuTHguwHoKmuRoSuGa3tINolTPeRu0qRevqWnlcFJfF0mmVlzFQpRfhDefW/HJsIjoEJTtaJBSUIJpef/nEBxYcDfKRPT9Ntjok3QsR97KWgE2QFXFTWQ4eLkHj3N8RhCNEoAgcRm/xJWwHJe7yetE3RWI9txCWhBvdlDG7DgmTjVGoMj//03//qEf/ZV3/+zK70tYauKZ0xWwwS+AmNpbvUlzKFm4jerlEr5Ks/Mp/0PfAaBtNEh6+0LQzXCbxzJvtkjPPpCR9mtH+ZP/BqH2Se4QKflwq6DWTIB9956LrxOoP+McNIusq2BidifADVB9kAoVxvVBgbK23yQAAAA=
Ipo Date
2000-08-04T00:00:00.000Z
Market Cap
7449674752
Next Dividend Date
2026-01-02T00:00:00.000Z
Dividend Frequency
Quarterly
Dividend Rate
0.05
Dividend Yield
0.44316419233325943
Sentiment
0.9417096774193549
Sentiment Sources
31
Rating
3.8571
Target Price
48.8333
Strong Buy
5
Buy
2
Hold
7
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
860500000
Cost Of Revenue
474300000
Gross Profit
386200000
Operating Expenses
319300000
Operating Income
66900000
Interest Expense
20000000
Pretax Income
-72600000
Net Income
-59600000
Eps
-0.3926218708827404
Dividends Per Share
0
Shares Outstanding
151941144
Income Tax Expense
-14100000
EBITDA
3100000
Operating Margin
7.774549680418362
Total Other Income Expense Net
-139500000
Cash
295000000
Short Term Investments
-
Receivables
673400000
Inventories
1196600000
Total Current Assets
2350600000
Property Plant Equipment
746700000
Total Assets
6434900000
Payables
184400000
Short Term Debt
24300000
Long Term Debt
1984200000
Total Liabilities
3942500000
Equity
2431900000
Depreciation
55700000
Change In Working Capital
100000
Cash From Operations
-33200000
Capital Expenditures
20900000
Cash From Investing
-23800000
Cash From Financing
258399999
Net Change In Cash
201100000
PE
-
PB
2.8170294831201943
ROE
-2.450758666063572
ROA
-0.9261993193367419
FCF
-54100000
Fcf Percent
-0.06287042417199303
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
1.5
Defensive Investing Score
6
Dividend Investing Score
2
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
6
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
860500000
Quarters > 0 > income Statement > cost Of Revenue
474300000
Quarters > 0 > income Statement > gross Profit
386200000
Quarters > 0 > income Statement > operating Expenses
319300000
Quarters > 0 > income Statement > operating Income
66900000
Quarters > 0 > income Statement > interest Expense
20000000
Quarters > 0 > income Statement > pretax Income
-72600000
Quarters > 0 > income Statement > net Income
-59600000
Quarters > 0 > income Statement > eps
-0.3926218708827404
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
151800000
Quarters > 0 > income Statement > income Tax Expense
-14100000
Quarters > 0 > income Statement > EBITDA
3100000
Quarters > 0 > income Statement > operating Margin
7.774549680418362
Quarters > 0 > income Statement > total Other Income Expense Net
-139500000
Quarters > 0 > balance Sheet > cash
295000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
673400000
Quarters > 0 > balance Sheet > inventories
1196600000
Quarters > 0 > balance Sheet > total Current Assets
2350600000
Quarters > 0 > balance Sheet > property Plant Equipment
746700000
Quarters > 0 > balance Sheet > total Assets
6434900000
Quarters > 0 > balance Sheet > payables
184400000
Quarters > 0 > balance Sheet > short Term Debt
24300000
Quarters > 0 > balance Sheet > long Term Debt
1984200000
Quarters > 0 > balance Sheet > total Liabilities
3942500000
Quarters > 0 > balance Sheet > equity
2431900000
Quarters > 0 > cash Flow > net Income
-59600000
Quarters > 0 > cash Flow > depreciation
55700000
Quarters > 0 > cash Flow > change In Working Capital
100000
Quarters > 0 > cash Flow > cash From Operations
-33200000
Quarters > 0 > cash Flow > capital Expenditures
20900000
Quarters > 0 > cash Flow > cash From Investing
-23800000
Quarters > 0 > cash Flow > cash From Financing
258399999
Quarters > 0 > cash Flow > net Change In Cash
201100000
Quarters > 0 > ratios > PE
-0.3926218708827404
Quarters > 0 > ratios > PB
2.8170294831201943
Quarters > 0 > ratios > ROE
-2.450758666063572
Quarters > 0 > ratios > ROA
-0.9261993193367419
Quarters > 0 > ratios > FCF
-54100000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.06287042417199303
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
797400000
Quarters > 1 > income Statement > cost Of Revenue
439500000
Quarters > 1 > income Statement > gross Profit
357900000
Quarters > 1 > income Statement > operating Expenses
346000000
Quarters > 1 > income Statement > operating Income
11900000
Quarters > 1 > income Statement > interest Expense
15700000
Quarters > 1 > income Statement > pretax Income
1100000
Quarters > 1 > income Statement > net Income
7600000
Quarters > 1 > income Statement > eps
0.05009887936717205
Quarters > 1 > income Statement > dividends Per Share
7600000
Quarters > 1 > income Statement > shares Outstanding
151700000
Quarters > 1 > income Statement > income Tax Expense
-3100000
Quarters > 1 > income Statement > EBITDA
72300000
Quarters > 1 > income Statement > operating Margin
1.492350137948332
Quarters > 1 > income Statement > total Other Income Expense Net
-10800000
Quarters > 1 > balance Sheet > cash
92000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
738700000
Quarters > 1 > balance Sheet > inventories
1218300000
Quarters > 1 > balance Sheet > total Current Assets
2162700000
Quarters > 1 > balance Sheet > property Plant Equipment
758500000
Quarters > 1 > balance Sheet > total Assets
6339800000
Quarters > 1 > balance Sheet > payables
243000000
Quarters > 1 > balance Sheet > short Term Debt
55700000
Quarters > 1 > balance Sheet > long Term Debt
2379600000
Quarters > 1 > balance Sheet > total Liabilities
4473000000
Quarters > 1 > balance Sheet > equity
1804000000
Quarters > 1 > cash Flow > net Income
4200000
Quarters > 1 > cash Flow > depreciation
56100000
Quarters > 1 > cash Flow > change In Working Capital
-160300000
Quarters > 1 > cash Flow > cash From Operations
-127500000
Quarters > 1 > cash Flow > capital Expenditures
21300000
Quarters > 1 > cash Flow > cash From Investing
-91100000
Quarters > 1 > cash Flow > cash From Financing
95500000
Quarters > 1 > cash Flow > net Change In Cash
-91500000
Quarters > 1 > ratios > PE
0.05009887936717205
Quarters > 1 > ratios > PB
3.7950227272727277
Quarters > 1 > ratios > ROE
0.42128603104212864
Quarters > 1 > ratios > ROA
0.11987759866241836
Quarters > 1 > ratios > FCF
-148800000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.18660647103085026
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
801400000
Quarters > 2 > income Statement > cost Of Revenue
410200000
Quarters > 2 > income Statement > gross Profit
391200000
Quarters > 2 > income Statement > operating Expenses
359400000
Quarters > 2 > income Statement > operating Income
31800000
Quarters > 2 > income Statement > interest Expense
13100000
Quarters > 2 > income Statement > pretax Income
25500000
Quarters > 2 > income Statement > net Income
17400000
Quarters > 2 > income Statement > eps
0.11454904542462147
Quarters > 2 > income Statement > dividends Per Share
7700000
Quarters > 2 > income Statement > shares Outstanding
151900000
Quarters > 2 > income Statement > income Tax Expense
8700000
Quarters > 2 > income Statement > EBITDA
88600000
Quarters > 2 > income Statement > operating Margin
3.9680559021712005
Quarters > 2 > income Statement > total Other Income Expense Net
-6300000
Quarters > 2 > balance Sheet > cash
184200000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
701100000
Quarters > 2 > balance Sheet > inventories
1116500000
Quarters > 2 > balance Sheet > total Current Assets
2111500000
Quarters > 2 > balance Sheet > property Plant Equipment
689000000
Quarters > 2 > balance Sheet > total Assets
5933100000
Quarters > 2 > balance Sheet > payables
244600000
Quarters > 2 > balance Sheet > short Term Debt
37700000
Quarters > 2 > balance Sheet > long Term Debt
2076100000
Quarters > 2 > balance Sheet > total Liabilities
4081900000
Quarters > 2 > balance Sheet > equity
1817200000
Quarters > 2 > cash Flow > net Income
16800000
Quarters > 2 > cash Flow > depreciation
50400000
Quarters > 2 > cash Flow > change In Working Capital
9300000
Quarters > 2 > cash Flow > cash From Operations
65000000
Quarters > 2 > cash Flow > capital Expenditures
26000000
Quarters > 2 > cash Flow > cash From Investing
-26100000
Quarters > 2 > cash Flow > cash From Financing
-51200000
Quarters > 2 > cash Flow > net Change In Cash
1000000
Quarters > 2 > ratios > PE
0.11454904542462147
Quarters > 2 > ratios > PB
3.7724229583975353
Quarters > 2 > ratios > ROE
0.9575170592119745
Quarters > 2 > ratios > ROA
0.2932699600546089
Quarters > 2 > ratios > FCF
39000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.04866483653606189
Quarters > 2 > health Score
36
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
979600000
Quarters > 3 > income Statement > cost Of Revenue
486300000
Quarters > 3 > income Statement > gross Profit
493300000
Quarters > 3 > income Statement > operating Expenses
421200000
Quarters > 3 > income Statement > operating Income
72100000
Quarters > 3 > income Statement > interest Expense
15600000
Quarters > 3 > income Statement > pretax Income
54600000
Quarters > 3 > income Statement > net Income
13700000
Quarters > 3 > income Statement > eps
0.09013157894736842
Quarters > 3 > income Statement > dividends Per Share
7600000
Quarters > 3 > income Statement > shares Outstanding
152000000
Quarters > 3 > income Statement > income Tax Expense
40700000
Quarters > 3 > income Statement > EBITDA
124600000
Quarters > 3 > income Statement > operating Margin
7.3601469987750106
Quarters > 3 > income Statement > total Other Income Expense Net
-17500000
Quarters > 3 > balance Sheet > cash
183400000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
701200000
Quarters > 3 > balance Sheet > inventories
1067800000
Quarters > 3 > balance Sheet > total Current Assets
2053200000
Quarters > 3 > balance Sheet > property Plant Equipment
814800000
Quarters > 3 > balance Sheet > total Assets
5806700000
Quarters > 3 > balance Sheet > payables
234100000
Quarters > 3 > balance Sheet > short Term Debt
64600000
Quarters > 3 > balance Sheet > long Term Debt
2061800000
Quarters > 3 > balance Sheet > total Liabilities
3991500000
Quarters > 3 > balance Sheet > equity
1781200000
Quarters > 3 > cash Flow > net Income
13900000
Quarters > 3 > cash Flow > depreciation
52900000
Quarters > 3 > cash Flow > change In Working Capital
91000000
Quarters > 3 > cash Flow > cash From Operations
190000000
Quarters > 3 > cash Flow > capital Expenditures
36700000
Quarters > 3 > cash Flow > cash From Investing
-60600000
Quarters > 3 > cash Flow > cash From Financing
-75000000
Quarters > 3 > cash Flow > net Change In Cash
35000000
Quarters > 3 > ratios > PE
0.09013157894736842
Quarters > 3 > ratios > PB
3.851201437233326
Quarters > 3 > ratios > ROE
0.7691443970357063
Quarters > 3 > ratios > ROA
0.23593435169717739
Quarters > 3 > ratios > FCF
153300000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.1564924458962842
Quarters > 3 > health Score
47
Valuation > metrics > PE
-0.3926218708827404
Valuation > metrics > PB
2.8170294831201943
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-2.450758666063572
Profitability > metrics > ROA
-2.5355228452310046
Profitability > metrics > Net Margin
-0.06926205694363742
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.621160409556314
Risk > metrics > Interest Coverage
3.345
Risk > final Score
43
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.263057019645425
Liquidity > metrics > Quick Ratio
5.5294681360804985
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
62.049772727272725
Prev Valuations > 1
62.27577041602465
Prev Valuations > 2
61.48798562766674
Prev Profitabilities > 0
3
Prev Profitabilities > 1
8
Prev Profitabilities > 2
6
Prev Risks > 0
21
Prev Risks > 1
28
Prev Risks > 2
36
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:17:51.964Z
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
0.05Next Payout:
Jan 2, 2026Yield:
0.4432 %JP Morgan Raises Price Target for BRKR to $55, Maintains Overwei GuruFocus
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$48.8333
Analyst Picks
Strong Buy
5
Buy
2
Hold
7
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 58.41% of the total shares of Bruker Corporation
1.
T. Rowe Price Investment Management,Inc.(7.5341%)
since
2025/06/30
2.
BlackRock Inc(7.3036%)
since
2025/06/30
3.
Vanguard Group Inc(6.8758%)
since
2025/06/30
4.
Pallas Capital Advisors LLC(6.2624%)
since
2025/06/30
5.
FMR Inc(5.5404%)
since
2025/06/30
6.
Orbis Allan Gray Ltd(3.0834%)
since
2025/06/30
7.
London Company of Virginia(2.6521%)
since
2025/06/30
8.
State Street Corp(2.4945%)
since
2025/06/30
9.
AQR Capital Management LLC(2.1927%)
since
2025/06/30
10.
OZ Management LLC(2.0266%)
since
2025/06/30
11.
Brown Advisory Holdings Inc(1.81%)
since
2025/06/30
12.
Citadel Advisors Llc(1.7878%)
since
2025/06/30
13.
Geode Capital Management, LLC(1.3568%)
since
2025/06/30
14.
Dimensional Fund Advisors, Inc.(1.2801%)
since
2025/06/30
15.
Goldman Sachs Group Inc(1.2707%)
since
2025/06/30
16.
Morgan Stanley - Brokerage Accounts(1.1354%)
since
2025/06/30
17.
Fidelity International Ltd(1.1212%)
since
2025/06/30
18.
Edmond de Rothschild Holding S.A.(0.9924%)
since
2025/06/30
19.
Vaughan Nelson Scarbrgh & Mccullough LP(0.8527%)
since
2025/06/30
20.
Ameriprise Financial Inc(0.8374%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.